epivax
Develops computational immunology tools for vaccine and biologics design.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 1998
- Employees
- 47
- Headquarters
- United States
- Type
- Private
- Funding
- Grant · $2M · 2022
- Subsidiaries
- EpiVax Therapeutics, GAIA Vaccine Foundation